Mast cell activation and degranulation machinery

The mast cell activation and degranulation machinery is a complex biological system comprising receptors, signaling molecules, and secretory proteins that coordinate the release of inflammatory mediators [1]. The primary trigger is the high-affinity IgE receptor (FcεRI), which, upon cross-linking by allergens, initiates a signaling cascade involving kinases such as Lyn, Fyn, and Syk [2]. This cascade leads to calcium mobilization and the activation of the SNARE (Soluble NSF Attachment Protein Receptor) complex, including proteins like SNAP-23 and Syntaxin-4, which facilitate the fusion of secretory granules with the cell membrane [3, 4]. This machinery plays a central role in the pathophysiology of Type I hypersensitivity reactions, including allergic rhinitis, asthma, and life-threatening anaphylaxis [5]. Therapeutic agents targeting this machinery include mast cell stabilizers like cromolyn sodium, which inhibit granule release, and monoclonal antibodies like omalizumab, which prevent IgE-mediated activation [6]. Additionally, small-molecule inhibitors of downstream kinases like Syk and KIT are used to modulate mast cell activity in various inflammatory and neoplastic conditions [7].

Other names

Mast cell degranulation pathwayFcεRI signaling cascadeMast cell secretory machineryMast cell activation pathway

Inhibition of IgE-mediated signaling, stabilization of the mast cell membrane to prevent calcium influx and granule fusion, and inhibition of downstream kinases such as Syk and KIT.